drugset / Trial / NCT00443924

Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma

NCT00443924 ↗

Phase 1 Completed 56 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this trial is to evaluate the safety and tolerability of INS115644 Ophthalmic Solution in subjects with bilateral ocular hypertension or early primary open angle glaucoma and to investigate the intraocular pressure lowering effects of INS115644 Ophthalmic Solution.

Timeline

Start
2007-03
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject INS115644 Unknown — Other